13F-HR filed by STEMPOINT CAPITAL LP
STEMPOINT CAPITAL LP filed this 13F-HR for the quarter ended 2025-09-30, filed 2025-11-14, with 87 holding rows worth $499,089,412.
- Accession
- 0001420506-25-003308
- Filer
- CIK 1952142
- Filed
- 2025-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2025
A holdings report, 90 entries on the cover page, a total value of $499,089,412 stated on the cover page (in dollars after the unit check, H1), rows summing to $499,089,412 with VALUE read as dollars as filed, 13F file number 028-23724. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ROIVANT SCIENCES LTD | G76279101 | SHS | 4,197,187 | $63,503,439 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 522,155 | $30,478,187 | dollars as filed | |
| SCHOLAR ROCK HLDG CORP | 80706P103 | COM | 726,204 | $27,043,837 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 1,589,580 | $25,624,030 | dollars as filed | |
| DENALI THERAPEUTICS INC COM | 24823R105 | Stock | 1,734,659 | $25,187,249 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 1,366,205 | $21,019,064 | dollars as filed | |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 655,385 | $15,893,086 | dollars as filed | |
| WAVE LIFE SCIENCES LTD SHS | Y95308105 | Stock | 2,110,152 | $15,446,313 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 1,017,311 | $15,269,838 | dollars as filed | |
| CIDARA THERAPEUTICS INC | 171757206 | COM NEW | 152,325 | $14,586,642 | dollars as filed | |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 166,273 | $14,116,578 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 371,825 | $10,117,358 | dollars as filed | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 91,444 | $9,234,930 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 12,465 | $9,193,685 | dollars as filed | |
| SURROZEN INC | 86889P208 | COMMON STOCK | 713,463 | $9,192,971 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 185,380 | $8,657,246 | dollars as filed | |
| REZOLUTE INC | 76200L309 | COMMON STOCK | 917,630 | $8,625,722 | dollars as filed | |
| GH RESEARCH PLC ORDINARY SHARES | G3855L106 | Stock | 545,275 | $7,797,433 | dollars as filed | |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | COM | 411,893 | $7,764,183 | dollars as filed | |
| VISTAGEN THERAPEUTICS INC | 92840H400 | COM | 2,488,685 | $7,749,263 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 192,295 | $7,720,644 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 241,637 | $7,249,110 | dollars as filed | |
| CELCUITY INC | 15102K100 | COM | 136,710 | $6,753,474 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 127,435 | $6,618,974 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 43,419 | $6,251,468 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 474,612 | $6,003,842 | dollars as filed | |
| MINERALYS THERAPEUTICS INC | 603170101 | COM | 158,112 | $5,995,607 | dollars as filed | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 121,410 | $5,764,547 | dollars as filed | |
| JAZZ PHARMACEUTICALS PLC SHS USD | G50871105 | Stock | 39,072 | $5,149,690 | dollars as filed | |
| AVIDITY BIOSCIENCES INC COM | 05370A108 | Stock | 114,053 | $4,969,289 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV | N62509109 | COMMON STOCK | 150,573 | $4,282,296 | dollars as filed | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 359,470 | $4,202,204 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 8,207 | $3,764,223 | dollars as filed | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 276,884 | $3,761,968 | dollars as filed | |
| INCYTE CORP COM | 45337C102 | Stock | 43,754 | $3,710,777 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 129,335 | $3,621,380 | dollars as filed | |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 350,710 | $3,208,997 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 47,954 | $3,185,584 | dollars as filed | |
| NEKTAR THERAPEUTICS | 640268306 | COMMON STOCK | 53,201 | $3,027,137 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 15,149 | $3,011,773 | dollars as filed | |
| TECTONIC THERAPEUTIC INC | 878972108 | COMMON STOCK | 188,999 | $2,965,394 | dollars as filed | |
| HARROW INC | 415858109 | COM | 57,619 | $2,776,083 | dollars as filed | |
| TAYSHA GENE THERAPIES INC | 877619106 | COMMON STOCK | 839,669 | $2,745,718 | dollars as filed | |
| EQUILLIUM INC | 29446K106 | COM | 1,908,935 | $2,729,777 | dollars as filed | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 6,264 | $2,625,931 | dollars as filed | |
| CG ONCOLOGY INC | 156944100 | COMMON STOCK | 63,019 | $2,538,405 | dollars as filed | |
| INVESCO QQQ TR | 46090E103 | COM | 3,797 | $2,279,605 | dollars as filed | |
| BRIDGEBIO ONCOLOGY THERAPEUT | 107924102 | COM NEW | 186,614 | $2,160,990 | dollars as filed | |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 245,378 | $2,061,175 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 166,461 | $1,997,532 | dollars as filed | |
| X4 PHARMACEUTICALS INC | 98420X202 | COMMON STOCK | 555,411 | $1,899,506 | dollars as filed | |
| PEPGEN INC COM | 713317105 | Stock | 389,189 | $1,798,053 | dollars as filed | |
| ASSEMBLY BIOSCIENCES INC | 045396207 | COMMON STOCK | 66,130 | $1,692,928 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 41,382 | $1,628,382 | dollars as filed | |
| PERCEPTIVE CAPITAL SOLUTIONS | G70077105 | CL A ORD SHS | 150,000 | $1,590,000 | dollars as filed | |
| PROTARA THERAPEUTICS INC | 74365U107 | COM STK | 363,666 | $1,581,947 | dollars as filed | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 275,620 | $1,579,303 | dollars as filed | |
| PYXIS ONCOLOGY INC COMMON STOCK | 747324101 | Stock | 689,538 | $1,530,774 | dollars as filed | |
| MBX BIOSCIENCES INC COM | 55287L101 | Stock | 75,000 | $1,312,500 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 480,000 | $1,188,000 | dollars as filed | call |
| ADC THERAPEUTICS SA | H0036K147 | COMMON STOCK | 283,286 | $1,133,144 | dollars as filed | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 11,376 | $933,970 | dollars as filed | |
| Arbutus Biopharma Corp | 03879J100 | Common Shares, without par value | 205,388 | $932,462 | dollars as filed | |
| MIND MEDICINE MINDMED INC | 60255C885 | COM NEW | 76,875 | $906,356 | dollars as filed | |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 172,500 | $905,625 | dollars as filed | call |
| ENANTA PHARMACEUTICALS INC | 29251M106 | COM | 75,194 | $900,072 | dollars as filed | |
| ZENAS BIOPHARMA INC COM | 98937L105 | Stock | 38,742 | $860,072 | dollars as filed | |
| WHITEHAWK THERAPEUTICS INC | 00032Q104 | CMN | 424,082 | $805,756 | dollars as filed | |
| SPDR SER TR | 78464A870 | S&P BIOTECH | 1,490,100 | $725,352 | dollars as filed | put |
| CORVUS PHARMACEUTICALS INC | 221015100 | COM | 96,439 | $710,755 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 56,770 | $691,459 | dollars as filed | |
| MEIRAGTX HOLDINGS PLC | G59665102 | COMMON STOCK | 81,858 | $673,691 | dollars as filed | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 89,617 | $673,024 | dollars as filed | |
| ARCTURUS THERAPEUTICS HLDGS | 03969T109 | COM | 35,606 | $656,219 | dollars as filed | |
| Ventyx Biosciences Inc | 92332V107 | Common Stock | 167,470 | $520,832 | dollars as filed | |
| ATAIBECKLEY INC | N0731H103 | Equity | 76,032 | $402,209 | dollars as filed | |
| CLEARPOINT NEURO INC | 18507C103 | COM | 16,651 | $362,825 | dollars as filed | |
| INVIVYD INC | 00534A102 | COMMON STOCK | 278,608 | $306,469 | dollars as filed | |
| INVENTIVA SA | 46124U107 | ADS | 30,824 | $178,471 | dollars as filed | |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 50,000 | $137,500 | dollars as filed | call |
| CRISPR THERAPEUTICS AG NAMEN AKT | H17182108 | Stock | 40,000 | $59,000 | dollars as filed | call |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 100,000 | $55,000 | dollars as filed | call |
| IMMUNOVANT INC | 45258J102 | COM | 250,000 | $50,000 | dollars as filed | call |
| ARK ETF TR | 00214Q302 | GENOMIC REV ETF | 200,000 | $30,000 | dollars as filed | call |
| SCHOLAR ROCK HLDG CORP | 80706P103 | COM | 18,400 | $23,920 | dollars as filed | call |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 15,500 | $9,688 | dollars as filed | put |
| Arbutus Biopharma Corp | 03879J100 | Common Shares, without par value | 95,000 | $9,500 | dollars as filed | call |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-25-003308 | this filing | 2025-11-14 | acceptance time not in the bulk data set |